Pathophysiology of Sickle Cell Anemia in India for African Patients

Pathophysiology of Sickle Cell Anemia in India for African Patients for Nigeria & Kenya. Let GetWellGo plan your expert treatment & a warm, supportive stay.

Pathophysiology of Sickle Cell Anemia in India for African Patients

  • Category

    Oncology

  • Published By

    GetWellGo Team

  • Updated on

    30-Jun-2025

Pathophysiology of Sickle Cell Anemia

Sickle Cell Anemia is an inherited blood disease resulting from a mutation in the β-globin gene of hemoglobin (HBB gene), which results in the production of abnormal hemoglobin referred to as hemoglobin S (HbS). The disease's pathophysiology results from multiple interdependent processes:

Pathophysiology of Sickle Cell Anemia:

Genetic Mutation and Hemoglobin Structure

  • Cause: A point mutation in the β-globin gene on chromosome 11.
  • Result: Replacement of glutamic acid by valine at position 6 of the β-globin chain.
  • Effect: Production of sickle hemoglobin (HbS) rather than normal adult hemoglobin (HbA).

Polymerization of Hemoglobin 

  • Under low oxygen (hypoxic) conditions, HbS polymerizes (gels), resulting in long, hard rods.
  • This deforms red blood cells (RBCs) into a sickle or crescent shape.

Red Blood Cell Sickling

Sickled RBCs are:

  • Hard and less flexible
  • Susceptible to hemolysis (breaking up prematurely)
  • Have a shorter life span (~10–20 days compared to 120 days for healthy RBCs)

Vaso-occlusion

Sickled cells:

  • Become trapped in small capillaries
  • Produce blockages (vaso-occlusion) in blood flow
  • Result in tissue ischemia, pain (sickle cell crises), and damage to organs

Hemolysis and Anemia

Chronic sickled cell destruction leads to:

  • Hemolytic anemia (low hemoglobin levels)
  • Hyperbilirubinemia (due to RBC breakdown)
  • Gallstones (due to elevated bilirubin)

Inflammation and Endothelial Dysfunction

Vaso-occlusion and ischemia induce:

  • Inflammatory cytokines
  • Endothelial activation and damage
  • More adhesion of leukocytes and sickled cells to blood vessel walls

Complications Derived from Pathophysiology of Sickle Cell Anemia

  • Pain crisis
  • Stroke
  • Acute chest syndrome
  • Infection (resulting from splenic dysfunction)
  • Damage to organs (kidneys, liver, eyes)

Sickle cell anemia complications

Sickle Cell Anemia (SCA) is a multisystem disease resulting from abnormal hemoglobin S, causing chronic hemolysis, vaso-occlusion, and organ injury. Complications are either acute or chronic, involving almost all the organ systems.

Acute Complications

Painful Crises (Vaso-occlusive Crisis)

  • Most frequent; because of obstructed blood supply in small blood vessels; bone, chest, and abdominal pain

Acute Chest Syndrome

  • Deadly; pain in the chest, fever, hypoxia; because of infection or fat emboli; mimics pneumonia

Stroke (Ischemic or Hemorrhagic)

  • Frequent in children and young adults because of occlusion of cerebral vessels

Splenic Sequestration Crisis

  • Abrupt accumulation of blood in the spleen → hypovolemia and shock; predominantly in children

Aplastic Crisis

  • Commonly precipitated by parvovirus B19; abrupt decrease in RBC output → profound anemia

Hemolytic Crisis

  • Acute RBC destruction resulting in escalating anemia, jaundice

Priapism

  • Prolonged, painful erection caused by penile blood vessel occlusion; may lead to irreversible damage

Chronic Complications

Hematologic

  • Chronic anemia, gallstones (due to bilirubin), retarded growth

Skeletal

  • Avascular necrosis (hip, shoulder), osteoporosis, bone infarcts

Neurologic

  • Silent strokes, intellectual impairment, overt stroke

Ophthalmologic

  • Proliferative sickle retinopathy → blindness

Renal

  • Hematuria, hyposthenuria (failure to concentrate urine), chronic kidney disease

Hepatic

  • Liver congestion, gallstones, hepatomegaly

Pulmonary

  • Pulmonary hypertension, chronic lung disease

Cardiac

  • Cardiomegaly, heart failure, predisposition to sudden death

Immunologic

  • Functional asplenia → predisposition to infection (particularly encapsulated organisms such as Streptococcus pneumoniae)

Dermatologic

  • Leg ulcers (particularly about the ankles)

Is there a cure for sickle cell via BMT?

Yes, BMT is currently the only curative therapy for sickle cell disease that is generally available. This involves substitution of the defective bone marrow with normal stem cells from a donor, and consequently the body starts generating normal blood cells.

Half-matched (haploidentical) BMT for Sickle cell

What exactly is haploidentical BMT?

The donor in a haploidentical transplant is a half match (50%), usually:

  • Parent
  • Child
  • Sibling

This matters because many patients don’t have a fully matched sibling, but nearly everyone has a half-matched family donor.

How it works

  • Patient’s diseased bone marrow is destroyed using chemotherapy
  • Healthy stem cells from the half-matched donor are infused
  • New marrow begins to produce normal red blood cells, rather than sickle-shaped ones.
  • Modern protocols have made this much safer and more successful.

Why haploidentical BMT is important?

  • Broadens donor pool to virtually all patients
  • Enables cure without a perfect match
  • Frequently utilized for international patients (such as in African countries where sickle cell is widespread)

Cost of BMT in India for Africans

The cost of BMT in India for African patients is $10,000.

What the price covers

Package pricing is also offered by the majority of hospitals for:

  • Pre-transplant tests
  • Chemotherapy
  • Transplant procedure
  • ICU + isolation room (3–6 weeks)
  • Drugs & initial follow-up

Success rates of BMT in Indian hospitals for African Patients

BMT success rates in India for African Patients-Nigeria, Kenya, Uganda (Sickle Cell)

  • Overall survival: ~87%
  • Matched sibling transplant: 96%
  • Half matched (haploidentical): ~78%

Why African Patients Choose GetWellGo for Pathophysiology of Sickle Cell Anemia?

GetWellGo is regarded as a leading supplier of healthcare services. We help our patients from Nigeria, Kenya, Uganda to choose the best treatment locations that suit their needs both financially and medically.

We offer:

  • Complete transparency
  • Fair costs.
  • 24 hour availability.
  • Medical E-visas
  • Online consultation from recognized Indian experts.
  • Assistance in selecting India's top hospitals for pathophysiology of sickle cell anemia.
  • Expert doctors with a strong track record of success
  • Assistance during and after the course of treatment.
  • Language Support
  • Travel and Accommodation Services
  • Case manager assigned to every patient to provide seamless support in and out of the hospital like appointment booking
  • Local SIM Cards
  • Currency Exchange
  • Arranging Patient’s local food

FAQs

How is the flight from Nigeria?

The duration of the flight from Nigeria to India varies with the city of departure, the destination, and whether there are stops on the route or not. 

  • Average Flight Duration
  • From Lagos to New Delhi 
  • Direct (rare): ~10–11 hours 
  • Connecting flights: ~12–16 hours

 How is the flight from Kenya?

Kenya to India flight time varies based on the city of departure, destination and whether you are flying directly or via a stopover.

  • Aggregate Flight Duration
  • Nairobi to New Delhi:
  • Direct flights: ~6–7 hours
  • Connecting flights: ~8–12 hours

Can I pay via wire transfer?

  • Yes, you can make payment by wire transfer for the sickle cell anemia via BMT in India. Most top-class Indian hospitals cater to African patients and accept African bank (wire) transfer as mode of payment. 

Are there other Nigerians/Kenyans at Fortis?

  • Yes there are definitely Nigerian/Kenyan patients at Fortis hospitals in India, including at Fortis Memorial Research Institute, Gurugram and many other Fortis centers. 

How can I apply for, obtain, or schedule in India?

  • We can assist you in finding the top hospitals in India. 
  • To schedule an appointment for sickle cell anemia via BMT in India, contact us via phone at +91-9289678787 or email us at care@getwellgo.com

Recent Blogs